Trials / Completed
CompletedNCT00986362
Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy
The MIC (Microplasmin In Children) Trial: A Randomized, Placebo-controlled, Double-masked, Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- ThromboGenics · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ocriplasmin | 175µg ocriplasmin intravitreal injection |
| DRUG | Placebo | Placebo intravitreal injection |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-12-01
- Completion
- 2012-04-01
- First posted
- 2009-09-29
- Last updated
- 2014-12-17
- Results posted
- 2014-02-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00986362. Inclusion in this directory is not an endorsement.